Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

Cell

Volumn 162, Issue 1, 2015, Pages 160-169

  Wang, Taia T ^a   Maamary, Jad ^a   Tan, Gene S ^b   Bournazos, Stylianos ^a   Davis, Carl W ^c   Krammer, Florian ^b   Schlesinger, Sarah J ^a   Palese, Peter ^b   Ahmed, Rafi ^c   Ravetch, Jeffrey V ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ANTIGEN RECEPTOR; CD23 ANTIGEN; FC RECEPTOR; GLYCOSYLTRANSFERASE; HEMAGGLUTININ ANTIBODY; IMMUNOGLOBULIN G; INFLUENZA VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG; VACCINE; VIRUS ANTIBODY; ANTIGEN ANTIBODY COMPLEX; IMMUNOGLOBULIN FC FRAGMENT; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; SIALIC ACID DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUCOSYLATION; HUMAN; HUMAN CELL; IMMUNIZATION; INFLUENZA VIRUS A H1N1; MEMORY CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SIALYLATION; VACCINATION; CHEMISTRY; IMMUNOLOGY; METABOLISM; PLASMA CELL;

ORTHOMYXOVIRIDAE;

ANTIBODIES, NEUTRALIZING; ANTIGEN-ANTIBODY COMPLEX; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INFLUENZA VACCINES; PLASMA CELLS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, FC; SIALIC ACIDS;

EID: 84934290153     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.06.026     Document Type: Article

References (45)

1. A.A. Ahmed, J. Giddens, A. Pincetic, J.V. Lomino, J.V. Ravetch, L.X. Wang, and P.J. Bjorkman Structural characterization of anti-inflammatory immunoglobulin G Fc proteins J. Mol. Biol. 426 2014 3166 3179
2. R.M. Anthony, and J.V. Ravetch A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs J. Clin. Immunol. 30 1 2010 S9 S14
3. R.M. Anthony, F. Nimmerjahn, D.J. Ashline, V.N. Reinhold, J.C. Paulson, and J.V. Ravetch Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc Science 320 2008 373 376
4. R.M. Anthony, F. Wermeling, M.C. Karlsson, and J.V. Ravetch Identification of a receptor required for the anti-inflammatory activity of IVIG Proc. Natl. Acad. Sci. USA 105 2008 19571 19578
5. R.M. Anthony, T. Kobayashi, F. Wermeling, and J.V. Ravetch Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway Nature 475 2011 110 113
6. W.E. Beyer, A.M. Palache, M.J. Sprenger, E. Hendriksen, J.J. Tukker, R. Darioli, G.L. van der Water, N. Masurel, and A.D. Osterhaus Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults Vaccine 14 1996 1331 1339
7. S. Bolland, and J.V. Ravetch Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis Immunity 13 2000 277 285
8. S. Bournazos, F. Klein, J. Pietzsch, M.S. Seaman, M.C. Nussenzweig, and J.V. Ravetch Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity Cell 158 2014 1243 1253
9. S. Dalle, L. Reslan, T. Besseyre de Horts, S. Herveau, F. Herting, A. Plesa, T. Friess, P. Umana, C. Klein, and C. Dumontet Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody GA101 Mol. Cancer Ther. 10 2011 178 185
10. Y.A. de Man, R.J. Dolhain, and J.M. Hazes Disease activity or remission of rheumatoid arthritis before, during and following pregnancy Curr. Opin. Rheumatol. 26 2014 329 333
11. L. Dinca, S. Neuwirth, J. Schulman, and C. Bona Induction of antihemagglutinin antibodies by polyclonal antiidiotype antibodies Viral Immunol. 6 1993 75 84
12. C. Espy, W. Morelle, N. Kavian, P. Grange, C. Goulvestre, V. Viallon, C. Chéreau, C. Pagnoux, J.C. Michalski, and L. Guillevin Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's) Arthritis Rheum. 63 2011 2105 2115
13. C. Ferrara, S. Grau, C. Jäger, P. Sondermann, P. Brünker, I. Waldhauer, M. Hennig, A. Ruf, A.C. Rufer, and M. Stihle Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose Proc. Natl. Acad. Sci. USA 108 2011 12669 12674
14. H. Fukuyama, F. Nimmerjahn, and J.V. Ravetch The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells Nat. Immunol. 6 2005 99 106
15. R. Hai, F. Krammer, G.S. Tan, N. Pica, D. Eggink, J. Maamary, I. Margine, R.A. Albrecht, and P. Palese Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes J. Virol. 86 2012 5774 5781
16. L.A. Herzenberg, S.J. Black, T. Tokuhisa, and L.A. Herzenberg Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors J. Exp. Med. 151 1980 1071 1087
17. J. Hodoniczky, Y.Z. Zheng, and D.C. James Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro Biotechnol. Prog. 21 2005 1644 1652
18. T.T. Junttila, K. Parsons, C. Olsson, Y. Lu, Y. Xin, J. Theriault, L. Crocker, O. Pabonan, T. Baginski, and G. Meng Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer Cancer Res. 70 2010 4481 4489
19. T. Kaisho, F. Schwenk, and K. Rajewsky The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses Science 276 1997 412 415
20. Y. Kaneko, F. Nimmerjahn, and J.V. Ravetch Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation Science 313 2006 670 673
21. R. Kapur, I. Kustiawan, A. Vestrheim, C.A. Koeleman, R. Visser, H.K. Einarsdottir, L. Porcelijn, D. Jackson, B. Kumpel, and A.M. Deelder A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy Blood 123 2014 471 480
22. F. Krammer, N. Pica, R. Hai, I. Margine, and P. Palese Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies J. Virol. 87 2013 6542 6550
23. A. Morell, W.D. Terry, and T.A. Waldmann Metabolic properties of IgG subclasses in man J. Clin. Invest. 49 1970 673 680
24. H.I. Nakaya, J. Wrammert, E.K. Lee, L. Racioppi, S. Marie-Kunze, W.N. Haining, A.R. Means, S.P. Kasturi, N. Khan, and G.M. Li Systems biology of vaccination for seasonal influenza in humans Nat. Immunol. 12 2011 786 795
25. G.J. Nossal The molecular and cellular basis of affinity maturation in the antibody response Cell 68 1992 1 2
26. R.N. Pearse, T. Kawabe, S. Bolland, R. Guinamard, T. Kurosaki, and J.V. Ravetch SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis Immunity 10 1999 753 760
27. N. Pica, R. Hai, F. Krammer, T.T. Wang, J. Maamary, D. Eggink, G.S. Tan, J.C. Krause, T. Moran, and C.R. Stein Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses Proc. Natl. Acad. Sci. USA 109 2012 2573 2578
28. A. Pincetic, S. Bournazos, D.J. DiLillo, J. Maamary, T.T. Wang, R. Dahan, B.M. Fiebiger, and J.V. Ravetch Type I and type II Fc receptors regulate innate and adaptive immunity Nat. Immunol. 15 2014 707 716
29. D. Pinna, D. Corti, D. Jarrossay, F. Sallusto, and A. Lanzavecchia Clonal dissection of the human memory B-cell repertoire following infection and vaccination Eur. J. Immunol. 39 2009 1260 1270
30. S. Sasaki, X.S. He, T.H. Holmes, C.L. Dekker, G.W. Kemble, A.M. Arvin, and H.B. Greenberg Influence of prior influenza vaccination on antibody and B-cell responses PLoS ONE 3 2008 e2975
31. H.U. Scherer, D. van der Woude, A. Ioan-Facsinay, H. el Bannoudi, L.A. Trouw, J. Wang, T. Häupl, G.R. Burmester, A.M. Deelder, and T.W. Huizinga Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid Arthritis Rheum. 62 2010 1620 1629
32. M.H. Selman, S.E. de Jong, D. Soonawala, F.P. Kroon, A.A. Adegnika, A.M. Deelder, C.H. Hokke, M. Yazdanbakhsh, and M. Wuhrer Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination Mol. Cell. Proteomics 11 2012 014563
33. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, and L.G. Presta Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity J. Biol. Chem. 277 2002 26733 26740
34. T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-Hosaka, Y. Kanda, M. Sakurada, K. Uchida, H. Anazawa, M. Satoh, and M. Yamasaki The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity J. Biol. Chem. 278 2003 3466 3473
35. P. Sondermann, A. Pincetic, J. Maamary, K. Lammens, and J.V. Ravetch General mechanism for modulating immunoglobulin effector function Proc. Natl. Acad. Sci. USA 110 2013 9868 9872
36. M. Tomana, R.E. Schrohenloher, W.J. Koopman, G.S. Alarcón, and W.A. Paul Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases Arthritis Rheum. 31 1988 333 338
37. J.S. Tsang, P.L. Schwartzberg, Y. Kotliarov, A. Biancotto, Z. Xie, R.N. Germain, E. Wang, M.J. Olnes, M. Narayanan, H. Golding Baylor HIPC Center CHI Consortium Global analyses of human immune variation reveal baseline predictors of postvaccination responses Cell 157 2014 499 513
38. P. Umaña, J. Jean-Mairet, R. Moudry, H. Amstutz, and J.E. Bailey Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity Nat. Biotechnol. 17 1999 176 180
39. F.E. van de Geijn, M. Wuhrer, M.H. Selman, S.P. Willemsen, Y.A. de Man, A.M. Deelder, J.M. Hazes, and R.J. Dolhain Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study Arthritis Res. Ther. 11 2009 R193
40. N. Verma, M. Dimitrova, D.M. Carter, C.J. Crevar, T.M. Ross, H. Golding, and S. Khurana Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children J. Virol. 86 2012 5515 5522
41. T.T. Wang, G.S. Tan, R. Hai, N. Pica, E. Petersen, T.M. Moran, and P. Palese Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins PLoS Pathog. 6 2010 e1000796
42. N. Washburn, I. Schwab, D. Ortiz, N. Bhatnagar, J.C. Lansing, A. Medeiros, S. Tyler, D. Mekala, E. Cochran, and H. Sarvaiya Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity Proc. Natl. Acad. Sci. USA 112 2015 E1297 E1306
43. WHO WHO Manual on Animal Influenza Diagnosis and Surveillance 2002 World Health Organization
44. J. Wrammert, K. Smith, J. Miller, W.A. Langley, K. Kokko, C. Larsen, N.Y. Zheng, I. Mays, L. Garman, and C. Helms Rapid cloning of high-affinity human monoclonal antibodies against influenza virus Nature 453 2008 667 671
45. M. Wuhrer, K. Stavenhagen, C.A. Koeleman, M.H. Selman, L. Harper, B.C. Jacobs, C.O. Savage, R. Jefferis, A.M. Deelder, and M. Morgan Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation J. Proteome Res. 14 2015 1657 1665